Across TCGA pan-cancer cohorts, LINC02756 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC02756’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02756 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02756 is over-expressed in tumor.
KIRC are the cancer types where LINC02756 tumor–normal differential expression is most reproducible.